Metabolomics in Central Sensitivity Syndromes

Research Projects
Written by Ken Rothermich

  • Full citation: Miller JS, Rodriguez-Saona L, Hacksaw KV. Metabolomics in Central Sensitivity Syndromes. Metabolites. 2020;10(4):164. https://doi.org/10.3390/metabo10040164

  • Principal Investigator for CMRF Grant Award: Kevin V Hackshaw

  • Conclusions: “The majority of metabolomic studies addressing a CSS found significantly altered metabolites that allowed for differentiation of CSS patients from healthy controls. Therefore, the published literature overwhelmingly supports the use of metabolomics in CSS.”

View Abstract
Ken Rothermich
Previous

Urine and Plasma Complement Ba Levels During Disease Flares in Patients with Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis
Next

Inpatient Mortality in Transition-Aged Youth with Rheumatic Disease: An Analysis of the National Inpatient Sample